Utility of positron emission tomography in pediatric oncology

Zbigniew Kula; Ineza Szafrańska-Komarowska; Bogdan Małkowski

doi:10.5114/wo.2011.20527

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2011
vol. 15

Send email

Copy url:

abstract:

Review paper

Utility of positron emission tomography in pediatric oncology

Zbigniew Kula

,

Ineza Szafrańska-Komarowska

,

Bogdan Małkowski

Contemporary Oncology (2011) vol. 15; 1 (20–26)

DOI: https://doi.org/10.5114/wo.2011.20527

Online publish date: 2011/03/11

View full text Get citation

PlumX metrics:

Positron emission tomography (PET) is a novel, non-invasive function imaging method that is increasingly used for the primary staging of malignant diseases, detection of recurrence and assessment of therapeutic response. The combination of PET and computed tomography (PET/CT) improves the diagnostic capability of the method. The aim of this review is to present concisely the use of PET/CT in the pediatric oncology diagnostics. In the following chapters the author discusses the indication to the PET/CT examination according to the present knowledge and prospects of the PET development. PET/CT imaging can be effectively helpful for other useful diagnostic methods with are used in pediatric oncology. In Poland application of PET/CT should find wider use especially in children with lymphomas, central nervois system tumors, neuroblastoma, Wilms tumor, bone and soft tissue tumors.

keywords:

Utility of positron emission tomography in pediatric oncology

Zbigniew Kula , Ineza Szafrańska-Komarowska , Bogdan Małkowski

positron emission tomography, computed tomography, pediatric oncology

Zbigniew Kula

,

Ineza Szafrańska-Komarowska

,

Bogdan Małkowski